gma semaglutide is a medication that was initially approved for Type 2 diabetes, but is now allowed to be prescribed for weight loss too. MORE on what happens when you stop taking it Eli Lilly's oral GLP-1 pill

If youre experiencing menstrual changes while taking tirzepatide, consider asking whether your symptoms are related to weight loss, hormone fluctuations, ovulation changes, or an underlying condition such as PCOS

There are some concerns that semaglutide could reduce muscle mass and bone density, though were still learning more about this

The critical factors for safe concurrent use with GLP-1 medications are dose selection, timing relative to injection days, and individual tolerance profiles

Reduced Risk of Major Cardiovascular Events Clinical trials, such as the SUSTAIN-6 and PIONEER-6 studies, have demonstrated that Semaglutide can reduce the risk of major cardiovascular events, such as heart attack, stroke, and cardiovascular-related death

Less effective blood sugar management, for those using semaglutide for glycemic control, is another performance indicator